NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-TR-21-019 from the NIH Guide for Grants and Contracts
Notice NOT-MD-21-013 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-019 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-165 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide grant opportunities to universities with graduate programs in both mining and explosives engineering to 1) support research related to mine emergencies, and 2) build on the work of the National Institute for Occupational Safety and Health (NIOSH) to address mandates in the Mine Improvement and New Emergency Response Act of 2006 (P.L. 109-236) and P.L. 116-94 to advance the safety and health of mine workers in our nation.
Funding Opportunity PA-21-151 from the NIH Guide for Grants and Contracts. The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
Notice NOT-AA-21-005 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-319 from the NIH Guide for Grants and Contracts. The purpose of this FOA is the rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. Multidisciplinary teams of scientists and clinicians will focus on generating preclinical data that will lead to the development of biological interventions, such as gene therapy, cell-based therapy, pharmacological approaches, and/or medical devices. The ultimate goal of this program is to make technological, biological and pharmacological resources available to clinicians and their patients.
Notice NOT-OD-21-061 from the NIH Guide for Grants and Contracts
Notice NOT-AA-21-004 from the NIH Guide for Grants and Contracts
Notice NOT-AT-21-005 from the NIH Guide for Grants and Contracts
Notice NOT-NS-21-014 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-21-164 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.
Funding Opportunity RFA-AI-20-080 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support a Coordinating Center for the Human Immunology Project Consortium (HIPC) program. The HIPC program, supported through a separate FOA, will consist of 5-8 multi-project cooperative agreement (U19) awardees that will measure the diversity and commonalities of human immune responses under a variety of conditions and longitudinally using high-throughput systems immunology approaches coupled with detailed clinical phenotyping in well-characterized human cohorts. The HIPC Coordinating Center supported by this FOA will be responsible for: coordinating cross-HIPC data integration, analysis, and visualization; developing and maintaining a public HIPC website and knowledgebase to support cross-HIPC data analysis and visualization; and fostering collaborations amongst HIPC-funded investigators by managing the HIPC subcommittees and an Infrastructure and Opportunity Fund to support collaborative studies.
Funding Opportunity RFA-AI-20-079 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) for the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, vaccine adjuvants or natural infections by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will measure the diversity and commonalities of human immune responses under a variety of conditions and longitudinally using high-throughput systems immunology approaches coupled with detailed clinical phenotyping in well-characterized human cohorts. The resulting data will be used to develop molecular signatures that define immune response profiles and identify biomarkers that correlate with the outcomes of vaccinations, vaccine adjuvants or natural infections in humans. An additional goal of this program is to promote rapid public access to HIPC-supported data and meta-data through public portals such as ImmPort. A companion FOA will support development and operation of a HIPC Coordinating Center that will be responsible for fostering collaborations amongst HIPC-funded investigators; facilitating public dissemination of integrated HIPC findings and knowledge; and supporting development or adoption of new, robust methods for data integration, analysis, presentation, and visualization to further research and development in this field.
Notice NOT-AI-21-031 from the NIH Guide for Grants and Contracts
Notice NOT-HS-21-009 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-017 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-RM-21-011 from the NIH Guide for Grants and Contracts. Kids First has established and continues to develop a Data Resource including a large collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central portal where these data and analysis tools are accessible to the research community. This FOA is intended to engage experts in a variety of activities that will enhance the utility of childhood cancer and/or structural birth defects genomic datasets generated by the Kids First program and/or associated phenotypic datasets and resources. These activities should strengthen future analyses of Kids First datasets by the broader researcher community with the ultimate goal of improving diagnostic capabilities and therapies for children and their families affected by these conditions.
Notice NOT-OD-21-055 from the NIH Guide for Grants and Contracts
Notice NOT-GM-21-016 from the NIH Guide for Grants and Contracts